Argenx Se (ARGX) Cost of Revenue (2022 - 2026)

Argenx Se (ARGX) posted Cost of Revenue of $121.0 million for Q1 2026, down 19.16% on a QoQ basis from $149.7 million in Q4 2025, and up 49.38% year-over-year from $81.0 million in Q1 2025.

Argenx Se (ARGX) Cost of Revenue (2022 - 2026) Analysis & Trends

Argenx Se's Cost of Revenue history runs 5 years deep, the most recent figure standing at $121.0 million for Q1 2026.

  • Quarterly Cost of Revenue rose 49.38% year-over-year to $121.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $490.9 million (up 85.15% YoY) and the FY2025 annual result came in at $450.7 million, up 98.28% from the prior year.
  • Cost of Revenue was $121.0 million for Q1 2026 at Argenx Se, down from $149.7 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $149.7 million in Q4 2025 and bottomed at $1.4 million in Q1 2022.
  • A 5-year average of $55.7 million and a median of $43.2 million in 2024 frame the typical range for Cost of Revenue.
  • Annual changes were most pronounced in 2023 — Cost of Revenue jumped 1236.37% — and 2026, when it soared 49.38%.
  • Argenx Se's Cost of Revenue stood at $12.8 million in 2022, then jumped by 208.75% to $39.5 million in 2023, then soared by 84.05% to $72.7 million in 2024, then surged by 106.02% to $149.7 million in 2025, then decreased by 19.16% to $121.0 million in 2026.
  • Business Quant data shows ARGX's Cost of Revenue at $121.0 million in Q1 2026, $149.7 million in Q4 2025, and $109.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 167.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 392.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 296.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 121.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 207.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 121.00 Mn
Mar 31, 2026 121.00 Mn
Dec 31, 2025 149.69 Mn
Dec 31, 2025 149.69 Mn
Sep 30, 2025 109.43 Mn
Sep 30, 2025 109.43 Mn
Jun 30, 2025 110.75 Mn
Jun 30, 2025 110.75 Mn
Mar 31, 2025 81.00 Mn
Mar 31, 2025 81.00 Mn
Dec 31, 2024 72.66 Mn
Dec 31, 2024 72.66 Mn
Sep 30, 2024 59.07 Mn
Sep 30, 2024 59.07 Mn
Jun 30, 2024 52.38 Mn
Jun 30, 2024 52.38 Mn
Mar 31, 2024 43.18 Mn
Mar 31, 2024 43.18 Mn
Dec 31, 2023 39.48 Mn
Dec 31, 2023 39.48 Mn